Related Experiment Video

Updated: Jul 9, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome

E Gluckman1, J E Wagner

  • 1Hematology Department, Eurocord Hôpital, Saint Louis, Paris, France. eliane.gluckman@sls.aphp.fr

Bone Marrow Transplantation
|December 18, 2007
PubMed

Insights

Hereditary bone marrow failure syndromes are rare but crucial to diagnose in children and adults. Accurate diagnosis impacts treatment and bone marrow transplant outcomes for aplastic anemia.

Area of Science:

  • Hematology
  • Pediatric Hematology
  • Genetics

Background:

  • Aplastic anemia is a rare pediatric disorder, often idiopathic but sometimes hereditary.
  • Hereditary bone marrow failure (BMF) syndromes require consideration in both pediatric and adult patients.
  • Accurate diagnosis is critical for effective treatment and bone marrow transplantation.

Purpose of the Study:

  • To review recent treatment outcomes for Fanconi anemia and other hereditary BMF syndromes.
  • To highlight the importance of precise diagnosis in managing BMF syndromes.
  • To inform treatment strategies for rare bone marrow failure disorders.

Main Methods:

  • Literature review of recent studies on hereditary bone marrow failure syndromes.
  • Analysis of treatment results for Fanconi anemia and related disorders.
  • Synthesis of diagnostic considerations for BMF.

Main Results:

  • Recent treatment advancements offer improved prognoses for hereditary BMF syndromes.
  • Early and precise diagnosis significantly alters patient management and transplant success.
  • Fanconi anemia treatment shows promising recent outcomes.

Conclusions:

  • Consideration of hereditary BMF syndromes is essential in all aplastic anemia cases.
  • Precise diagnosis guides personalized treatment and improves bone marrow transplant efficacy.
  • Ongoing research in hereditary BMF syndromes is advancing therapeutic options.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.